Over
last
two
decades
,
recognized
head
neck
cancers
,
primarily
oropharynx
,
distinct
entity
causally
related
human
papilloma
virus
(
HPV
)
.

Fakhry
et
al
.

established
2008
tumors
strikingly
better
prognosis
improved
responsiveness
chemotherapy
well
chemoradiotherapy
favorable
survival
rates
.

Since
,
new
studies
contributed
increased
understanding
new
entity
,
ranging
detailed
understanding
genetic
fingerprint
risk
modifiers
smoking
successful
early
attempts
personalize
therapy
de-escalation
definitive
intent
treatment
setting
specific
evaluation
targeted
therapies
patient
population
.

This
Commentary
seeks
summarize
state
art
understanding
HPV-associated
head
neck
cancers
emerged
since
publication
seminal
findings
Fakhry
et
al
.

